Daré Bioscience presents DARE-IDDS drug delivery device at PODD conference
DARE•Daré Bioscience will showcase its investigational DARE-IDDS device at the Partnership Opportunities in Drug Delivery conference in Boston on October 29-30, 2026. The implantable platform is designed to deliver more than 100 programmable doses over months to years and remains in preclinical development, initially targeting contraception.
1. Conference presentation
Daré Bioscience will showcase its investigational DARE-IDDS drug-delivery device at the Partnership Opportunities in Drug Delivery conference in Boston on October 29-30, 2026. Liz Proos, vice president of product development, is scheduled to present on October 30 from 2:30 to 2:50 p.m. ET.
2. Device details
The implantable device is designed to deliver more than 100 programmable doses over months to years, with wireless treatment monitoring and adjustment. The platform is initially targeting contraception and remains in preclinical development.
